Earnings calls

DCW concall ledger

Every earnings call for DCW — management tone, guidance, KPIs and promise tracking, quarter by quarter.

DCW · 6 transcripts · Chemicals · latest Q4 FY26

Q4 FY26Published 06 May 2026Call held 06 May 2026

DCW Q4 FY26 Earnings Call Transcript & Analysis

Revenue₹609 cr+13% YoYEBITDA₹70 cr+14% YoYPAT₹18 cr+60% YoY

Revenue ₹609 cr (+13% YoY); EBITDA (incl. other income) ₹70 cr (+14% YoY); PAT ₹18 cr (+60% YoY). FY26 EBITDA grew by 11.2% YoY to Rs.240 crores.

Q3 FY26Published 11 Feb 2026Call held 11 Feb 2026

Revenue₹520 cr+10% YoYEBITDA₹50 cr−19% YoYPBT₹7.5 cr

Revenue (Q3 FY26) ₹520 cr (+10% YoY); EBITDA (Q3 FY26) ₹50 cr (−19% YoY); PBT (Q3 FY26) ₹8 cr. Revenue of ₹520 crores, up 9.6% YoY.

Q2 FY26Published 05 Nov 2025Call held 05 Nov 2025

Revenue₹539 cr+10% YoYEBITDA₹62.6 cr+51% YoYEBITDA Margin10.78%PAT₹13.8 cr

Revenue ₹539 cr (+10% YoY); EBITDA ₹63 cr (+51% YoY); EBITDA Margin 10.78%. Revenue for Q2 FY26 grew 10.22% YoY to ₹539 crores.

Q1 FY26Published 11 Aug 2025Call held 11 Aug 2025

Revenue₹475 cr−5% YoYEBITDA₹58 cr+12% YoYEBITDA Margin11.3%PAT₹11.4 cr+70% YoY

Revenue ₹475 cr (−5% YoY); EBITDA ₹58 cr (+12% YoY); EBITDA Margin 11.3%. PAT grew 70% YoY to ₹11.4 crores.

Q4 FY25Published 13 May 2025Call held 13 May 2025

Revenue₹538 cr−13% YoYEBITDA₹62 cr−11% YoYEBITDA Margin11%PAT₹30 cr+100% YoYROCE8%

Revenue ₹538 cr (−13% YoY); EBITDA ₹62 cr (−10% YoY); EBITDA Margin 11.0%. FY25 Revenue grew 7% YoY to ₹2,000 crores.

Q3 FY25Published 17 Feb 2025Call held 17 Feb 2025

Revenue₹474 cr+19% YoYEBITDA₹62 cr+164% YoYEBITDA Margin13%PBT₹20 cr

Revenue ₹474 cr (+19% YoY); EBITDA ₹62 cr (+164% YoY); EBITDA Margin 13%. Revenue from operations grew by 19.09% YoY to ₹474 crores.